Yale Center for Clinical Investigation

New Haven, Connecticut 06520-8028

2 studies enrolling now · 25 studies all time

What they study most

Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder), Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder), Advanced Solid Tumors, Alopecia Areata, Autosomal Dominant Polycystic Kidney Disease, COVID-19, Cardiovascular Diseases, Congenital Ichthyosis, Cutaneous Sarcoidosis, Diabetes, Diabetes Type 2

Studies at this site

• Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial — Recruiting now
• A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725 — Recruiting now
• EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway — Completed
• Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children — Completed
• A Vehicle Controlled Study to Evaluate Safety and Efficacy of Topical TMB-001 for Treatment of Congenital Ichthyosis — Completed
• The ASCEND Study: Evaluating TMB-001 in the Treatment of RXLI or ARCI Ichthyosis — Completed
• Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine — Running, not enrolling
• To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age. — Completed
• A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors — Completed
• Study to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients with Granuloma Annulare — Completed
• Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata — Completed
• Gender Differences in Prevalence of Undiagnosed Diabetes in ACS — Completed
• Age Related Changes in Calciotropic Hormones and Their Impact on Male Osteoporosis — Completed
• Safety and Efficacy of HMI-203 in ERT-Treated Adults With MPS II — Withdrawn before enrolling
• Investigating the Effect of Onyx Sorghum on Blood Glucose in Individuals With Type 2 Diabetes — Completed
• A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D) — Completed
• A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis — Completed
• Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare — Completed
• Prevention of Recurrence of Diverticulitis — Completed
• Does Mindfulness Enhance BMI in Obese Adolescents Enrolled in the Bright Bodies Weight Management Program? — Completed
• Impact of Diet and/or Exercise-induced Weight Loss on Cardiovascular Risk Factors — Completed
• C-reactive Protein and Endothelial Dysfunction in Women With Glucose Intolerance — Completed
• Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects — Completed
• Prevention of Type 2 Diabetes in Children With a Family-based Healthy Lifestyle Program — Completed
• Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD): The Role of Biomarkers in Predicting a Response to Therapy — Stopped early